Cancer du sein de l’homme: à propos de 6 cas

Laabadi, Kamilia; Jayi, Sofia; Alaoui, Fatimazohra Fdili; Bouguern, Hakima; Chaara, Hikmat; Melhouf, Moulay Abdelilah; Hassani, Karim Ibn Majdoub; Laalim, Said Ait; Anoun, Hicham; Toughraï, Imane; Mazaz, Khalid

doi:10.11604/pamj.2013.16.70.2345

Cited by 7 publications

(17 citation statements)

References 44 publications

(61 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Malignant tumors were exclusively represented by infiltrating ductal carcinomas according to several authors [6] [15]. The average age of onset was similar to other authors [16] [17] [18].…”

Section: Histopathological Aspects Of Nodulessupporting

confidence: 79%

Male Breast Nodules in Ouagadougou (Burkina Faso): Radiological and Histopathological Aspects

Ouedraogo¹,

Napon²,

Tiemtore³

et al. 2018

OJRad

View full text Add to dashboard Cite

Objective: To describe the radiological and histological aspects of breast nodules among men in our practice setting. Methodology: This is a descriptive and retrospective study conducted from January 2014 to October 2017. The study included male patients with breast nodules classified ACR3, 4 or 5 after a mammographic and ultrasound scan. These lesions were explored through an ultrasound-guided breast microbiopsy. The following are the variables collected: age, family history of breast cancer, medical history, ACR classification, nodule size, and anatomopathologic diagnosis. Results: 13 breast nodules were explored among 13 male subjects. Mammography and breast ultrasound enabled to identify one ACR3 lesion, 10 ACR4 lesions and 2 ACR5 lesions. The average age was 56.53 ± 14.63 years and the average size of the nodules 28.91 ± 13.62 mm. As for histology, there were seven malignant tumors and six benign tumors. The average age of patients with malignancy was 61.45 ± 13.62 years. The malignant nodules average size was 29.45 ± 12.54 mm. Malignant tumors exclusively consisted of invasive breast carcinomas while Benign ones consisted of dystrophic and inflammatory lesions. Conclusion: Most often Breast lesions among men had an indeterminate appearance on imaging and were predominantly malignant in histopathology.

show abstract

Section: Histopathological Aspects Of Nodulessupporting

confidence: 79%

Male Breast Nodules in Ouagadougou (Burkina Faso): Radiological and Histopathological Aspects

Ouedraogo¹,

Napon²,

Tiemtore³

et al. 2018

OJRad

View full text Add to dashboard Cite

show abstract

“…Dans une série de 31 cas de carcinome canalaire in situ, Cutuli et al montrent trois rechutes après six tumorectomies (50%) alors qu'ils ne retrouvent qu'un seul cas de rechute pour 25 mastectomies. La petite taille de la glande mammaire rend difficile le passage en marges saines [ 18 ]. La tumorectomie n'est donc pas recommandée [ 12 - 15 ].…”

Section: Discussionunclassified

Cancer du sein chez l'homme: à propos de 40 cas et revue de la littérature

Elbachiri¹,

S²,

Bouchbika³

et al. 2017

Pan Afr Med J

View full text Add to dashboard Cite

Le cancer du sein chez l'homme est une affection rare représentant environ 1% de tous les cancers du sein et moins de 1% de l'ensemble des néoplasies masculines. L'objectif de notre étude est de décrire les différents aspects cliniques, histologique, pronostic et thérapeutiques de cette tumeur rare afin de contribuer à l'amélioration de la prise en charge de cette affection. Il s'agit d'une étude rétrospective portant sur 40 patients colligés au Centre Mohamed VI pour le traitement des cancers de Casablanca de Janvier 2000 à Décembre 2012. L'âge médian a été de 62 ans, le délai moyen de consultation a été de 12 mois, l'autopalpation d'un nodule péri aréolaire a été le principal motif de consultation dans 90% des cas. Le carcinome canalaire infiltrant a été le type histologique prédominant dans 90% des cas. La prise en charge thérapeutique multimodale a consisté en une mastectomie suivie d'un traitement adjuvant à type de chimiothérapie, radiothérapie et/ou hormonothérapie en fonction du stade de la tumeur et des caractéristiques histologiques. Le suivi moyen a été de 38 mois, l'évolution a été caractérisée par une rémission complète chez 16 patients (soit 40%), rechute locale chez 3 patients (soit 7.5%) et par une rechute métastatique chez 5 patients (soit 12.5%). Le site métastatique le plus fréquent a été l'os (62%), suivi par le poumon et le foie. Le décès était survenu chez 10 patients (25%). Le cancer du sein chez l'homme présente des similitudes avec le cancer mammaire chez la femme. Mais il présente aussi beaucoup de particularités, d'où l'intérêt de mener des études prospectives randomisés à plus large échelle afin d'améliorer la prise en charge et le pronostic de cette affection dont l'impact psychosociale est considérable.

show abstract

“…In our series, 72.5% of the patients had lymphadenopathies that were palpable during the diagnosis. In the African literature, there were lymphadenopathies in 61.5 to 88.9% of cases [ 19 ].…”

Section: Discussionmentioning

confidence: 99%

“…The more the stage is advanced, the less the survival is good (chi-squared = 16.3, p < 0.0001). The literature reports 5-year survival at 75 to 100% for patients at stage I, 50–80% for stage II, and 30–60% for stage III [ 19 , 28 , 34 , 35 ]. Age is described as an independent survival factor [ 6 , 36 ].…”

Section: Discussionmentioning

confidence: 99%

Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso)

et al. 2018

View full text Add to dashboard Cite

BackgroundMale breast cancer is a rare and less known disease. Therapeutic modalities affect survival. In Burkina Faso, male breast cancers are diagnosed in everyday practice, but the prognosis at short-, middle-, and long-term remains unknown. The objective of this study is to study the diagnosis stages, therapeutic modalities, and 5-year survival in male breast cancer at the General Surgery Unit of Yalgado Ouedraogo University Hospital from 1990 to 2009.MethodsA cohort longitudinal study concerning cases of breast cancer diagnosed in man. Survival was assessed using the Kaplan–Meier method and survival curves were compared through the LogRank test.ResultsFifty-one cases of male breast cancer were followed-up, i.e., 2.6% of all breast cancers. Stages III and IV represented 88% of cases. Eleven patients (21.6%) were at metastatic stage. Patients were operated in 60.8% of cases. The surgery included axillary dissection in 25 (80.6%) out of 31 cases. Lumpectomy was performed on 6.5% of patients (2 cases). Fifteen (29.4%) and 11 (21.6%) patients underwent chemotherapy and hormonal therapy, respectively. The FAC protocol was mostly used. Radiation therapy was possible in two cases. The median deadline for follow-up was 14.8 months. A local recurrence was noticed in 3.2% of cases. The overall 5-year survival rate was 49.9%. The median survival was over 5 years for stages I and II. It was 54 down to 36 months for stages III and IV.ConclusionDiagnosis is late. The lack of immunohistochemistry makes it difficult to define the proportion of their hormonal dependence. Surgery is the basic treatment. Five-year survival is slow and the median survival depends on the diagnosis stage. It can be improved through awareness-raising campaigns and the conduct of individual screening.

show abstract

Cancer du sein de l’homme: à propos de 6 cas

Cited by 7 publications

References 44 publications

Male Breast Nodules in Ouagadougou (Burkina Faso): Radiological and Histopathological Aspects

Male Breast Nodules in Ouagadougou (Burkina Faso): Radiological and Histopathological Aspects

Cancer du sein chez l'homme: à propos de 40 cas et revue de la littérature

Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso)

Contact Info

Product

Resources

About